52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Mckesson Reports First-Quarter Adjusted Earnings Per Share Of $3.31
Change Healthcare Shares Open About 7.7 Pct Above IPO Price In Debut
Mckesson Says CEO John Hammergren's 2019 Compensation Was $17.4 Million - SEC Filing
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.
Biotechnology & Drugs
1 Post St
Edward A. Mueller
Independent Chairman of the Board
Brian Scott Tyler
President, Chief Executive Officer, Chief Operating Officer, Director
Britt J. Vitalone
Chief Financial Officer, Executive Vice President
Lori Ann Schechter
Executive Vice President, Chief Compliance Officer, General Counsel
Jorge L. Figueredo
Executive Vice President - Human Resources
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Drug wholesalers AmerisourceBergen Corp <ABC.N>, McKesson Corp <MCK.N> and Cardinal Health Inc <CAH.N> have proposed a $10 billion settlement for claims that they played a part in the U.S. opioid epidemic, Bloomberg reported on Tuesday, citing people familiar with negotiations...
McKesson Corp has escaped a proposed class action lawsuit alleging the drug distributor conspired with the manufacturers of thousands of generic medications to fix prices in order to earn billions of dollars.
U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.
U.S. drug distributor McKesson Corp reported a smaller fourth-quarter loss on Wednesday, as its surgical distribution business was boosted by the company's recent acquisition of Medical Specialties Distributors LLC.
Drug distributor McKesson Corp has agreed to pay $37 million to resolve a lawsuit by the state of West Virginia alleging it helped fuel a U.S. opioid epidemic by failing to stop suspicious orders of painkillers by pharmacies in the state.
Drug distributor McKesson Corp has agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold it responsible for contributing to the opioid epidemic, the state's attorney general said on Thursday.
The Food and Drug Administration on Tuesday said it had sent a warning letter to drug distributor McKesson Corp after it sent bottles of prescription opioids and other medications to pharmacies that had been tampered with.
Bankrupt obesity-drug maker Orexigen Therapeutics can keep $6.9 million it received from drug distributor McKesson Corp even though the former owes far more than that to a McKesson subsidiary, the judge overseeing the case ruled on Tuesday.
Change Healthcare LLC, a healthcare technology company majority-owned by U.S. drug wholesaler McKesson Corp <MCK.N>, has hired underwriters for an initial public offering that could value it at as much as $12 billion, including debt, people familiar with the matter said...
* MCKESSON BOARD OF DIRECTORS ELECTS BRAD LERMAN AS NEW INDEPENDENT DIRECTOR
* MCKESSON LAUNCHES MULTI-YEAR STRATEGIC GROWTH INITIATIVE; REAFFIRMS FISCAL 2018 OUTLOOK AND PROVIDES PRELIMINARY FISCAL 2019 OUTLOOK
* POLARITYTE ANNOUNCES APPOINTMENT OF MCKESSON’S WILLIE BOGAN TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:
* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL TWO-PART NOTE OFFERING OF UP TO EUR 750 MILLION - SEC FILING Source text : (http://bit.ly/2H0ogwC) Further company coverage:
* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL NOTES DUE 2028 OFFERING OF UP TO $600 MILLION - SEC FILING Source text : (http://bit.ly/2G22iIb) Further company coverage:
* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL OFFERING OF NOTES DUE 2020 - SEC FILING Source text - http://bit.ly/2FUEDJW Further company coverage:
U.S. drug wholesaler McKesson Corp <MCK.N> said prices of generic drugs were still competitive, but not as volatile as in 2017 when prices fell sharply, which should help the company as it benefits from a major tie-up with Walmart.
McKesson Corp posted a better-than-expected quarterly profit, as the biggest U.S. drug distributor continues to benefit from its tie-up with Walmart .
* Q3 GAAP EARNINGS PER SHARE $4.32 FROM CONTINUING OPERATIONS
McKesson Corp, the biggest U.S. drug distributor, reported a 42.6 percent rise in quarterly profit on Thursday, partly helped by a $370 million tax benefit related to changes to U.S. tax laws.
Kentucky's attorney general on Monday accused drug distributor McKesson Corp of helping fuel the opioid epidemic by failing to halt shipments of suspiciously large or frequent orders by pharmacies of prescription painkillers.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.